Seres Therapeutics (MCRB) Reports Q3 EPS of $0.72
Seres Therapeutics (NASDAQ: MCRB) reported Q3 EPS of $0.72. Revenue for the quarter came in at $126.7M.
For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.
Seres Therapeutics (NASDAQ: MCRB) reported Q3 EPS of $0.72. Revenue for the quarter came in at $126.7M.
For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.